Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

UHTUNIVERSAL HEALTH REALTY INCOME TRUST

NYSE · CIK 0000798783
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC6798 Real Estate Investment Trusts
FY end1231
XBRL facts322

Identity from submissions API

NameUNIVERSAL HEALTH REALTY INCOME TRUST
CIK0000798783
TickersUHT
ExchangesNYSE
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC6798 Real Estate Investment Trusts
EIN236858580
LEI—
Fiscal year end1231
State of incorporationMD MD
Phone610-265-0688
Website—
Investor website—
Owner org05 Real Estate & Construction
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
UNIVERSAL CORPORATE CTR
367 S GULPH RD
KING OF PRUSSIA
PA
19406
PA
Mailing address
UNIVERSAL CORPORATE CTR
367 S GULPH ROAD
KING OF PRUSSIA
PA
19406
PA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

No Financialist filing articles yet for this CIK.

SEC filings

791 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-06 10-Q 10-Q 0001193125-26-451858 001-09321 261532115 34 9321265 1 1
2026-10-27 8-K 8-K 2.02,9.01 0001193125-26-434277 001-09321 261490847 34 756531 1 1
2026-08-07 10-Q 10-Q 0001193125-26-340281 001-09321 261254218 34 9201500 1 1
2026-07-27 8-K 8-K 2.02,9.01 0001193125-26-318144 001-09321 261206005 34 730055 1 1
2026-07-08 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-001954 005-37839 261161270 34 11065
2026-06-11 4 PRIMARY DOCUMENT 0000798783-26-000029 4879
2026-06-11 4 PRIMARY DOCUMENT 0000798783-26-000022 4803
2026-06-11 4 PRIMARY DOCUMENT 0000798783-26-000020 4871
2026-06-11 4 PRIMARY DOCUMENT 0000798783-26-000017 4870
2026-06-11 4 PRIMARY DOCUMENT 0000798783-26-000015 5943
2026-06-11 4 PRIMARY DOCUMENT 0000798783-26-000013 4813
2026-06-11 4 PRIMARY DOCUMENT 0000798783-26-000011 4755
2026-06-11 4 PRIMARY DOCUMENT 0000798783-26-000009 4780
2026-06-11 4 PRIMARY DOCUMENT 0000798783-26-000006 4805
2026-06-11 4 PRIMARY DOCUMENT 0000798783-26-000004 4812
2026-06-11 8-K 8-K 5.02,5.07 0001193125-26-267569 001-09321 261083221 34 186008 1 1
2026-06-05 4 PRIMARY DOCUMENT 0000798783-26-000002 4569
2026-05-07 10-Q 10-Q 0001193125-26-211984 001-09321 26953634 34 9732485 1 1
2026-04-29 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002100121-26-000837 005-37839 26915484 34 7459
2026-04-28 DEFA14A DEFA14A 0001193125-26-183456 001-09321 26903038 34 1010066
2026-04-28 DEF 14A DEF 14A 0001193125-26-183412 001-09321 26903014 34 11449050 1 1
2026-04-28 ARS ARS 0001193125-26-183410 001-09321 26903012 34 2193096
2026-04-27 8-K 8-K 2.02,9.01 0001193125-26-182162 001-09321 26901381 34 488668 1 1
2026-04-24 8-K 8-K 1.01,2.03,9.01 0001193125-26-175196 001-09321 26890559 34 2196522 1 1
2026-03-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-002544 005-37839 26805116 34 7285
2026-02-25 8-K 8-K 2.02,9.01 0001193125-26-071714 001-09321 26679052 34 617464 1 1
2026-02-25 10-K 10-K 0001193125-26-071594 001-09321 26678788 34 17780315 1 1
2026-01-21 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-26-000732 005-37839 26545952 34 10876
2025-11-07 10-Q 10-Q 0001193125-25-272382 001-09321 251462858 34 9175128 1 1
2025-10-30 4 PRIMARY DOCUMENT 0000798783-25-000005 5645
2025-10-27 8-K 8-K 2.02,9.01 0001193125-25-251645 001-09321 251420182 34 608297 1 1
2025-08-08 10-Q 10-Q 0001193125-25-177000 001-09321 251198615 34 9083965 1 1
2025-07-28 8-K 8-K 2.02,9.01 0000950170-25-099202 001-09321 251155998 34 602312 1 1
2025-06-12 4 PRIMARY DOCUMENT 0001127602-25-017372 4734
2025-06-12 4 PRIMARY DOCUMENT 0001127602-25-017370 4742
2025-06-12 4 PRIMARY DOCUMENT 0001127602-25-017367 4733
2025-06-12 4 PRIMARY DOCUMENT 0001127602-25-017365 5806
2025-06-12 4 PRIMARY DOCUMENT 0001127602-25-017362 4676
2025-06-12 4 PRIMARY DOCUMENT 0001127602-25-017360 4618
2025-06-12 4 PRIMARY DOCUMENT 0001127602-25-017357 4643
2025-06-12 4 PRIMARY DOCUMENT 0001127602-25-017353 4675
2025-06-12 4 PRIMARY DOCUMENT 0001127602-25-017352 4668
2025-06-12 4 PRIMARY DOCUMENT 0001127602-25-017351 4666
2025-06-12 8-K 8-K 5.02,5.07 0000950170-25-085399 001-09321 251042917 34 187716 1 1
2025-06-09 4 PRIMARY DOCUMENT 0001127602-25-017085 4432
2025-05-08 10-Q 10-Q 0000950170-25-067009 001-09321 25926375 34 7840570 1 1
2025-04-28 8-K 8-K 2.02,9.01 0000950170-25-059340 001-09321 25880739 34 483844 1 1
2025-04-25 DEFA14A DEFA14A 0000950170-25-058315 001-09321 25869855 34 1460561
2025-04-25 DEF 14A DEF 14A 0000950170-25-058306 001-09321 25869813 34 16464806 1 1
2025-04-25 ARS ARS 0000950170-25-058303 001-09321 25869809 34 1363187
2025-02-26 8-K 8-K 2.02,9.01 0000950170-25-027870 001-09321 25670955 34 685473 1 1
2025-02-26 10-K 10-K 0000950170-25-027861 001-09321 25670915 34 17749316 1 1
2024-11-12 SC 13G/A UnitedStates_13G__UniversalH.txt 0000932471-24-001285 005-37839 241450306 34 6664
2024-11-08 SC 13G/A us91359e1055_110824.txt 0002012383-24-004018 005-37839 241442048 34 13923
2024-11-08 10-Q 10-Q 0000950170-24-124121 001-09321 241440909 34 8017137 1 1
2024-11-04 SC 13G/A UnitedStates_13G__UniversalH.txt 0000932471-24-000719 005-37839 241422476 34 6662
2024-10-24 8-K 8-K 2.02,9.01 0000950170-24-117069 001-09321 241392898 34 567788 1 1
2024-10-18 SC 13G/A us91359e1055_101824.txt 0002012383-24-000594 005-37839 241380562 34 13911
2024-10-18 SC 13G/A Universal_Health_Realty_Inc.htm 0000093751-24-000887 005-37839 241379512 34 56097
2024-10-02 8-K 8-K 1.01,2.03,9.01 0001193125-24-230879 001-09321 241345816 34 1102068 1 1
2024-08-08 10-Q 10-Q 0000950170-24-094044 001-09321 241188718 34 7728195 1 1
2024-07-24 8-K 8-K 2.02,9.01 0000950170-24-086074 001-09321 241138392 34 561096 1 1
2024-06-12 S-8 S-8 0000950170-24-072460 333-280142 241038599 33 148941
2024-06-06 4 PRIMARY DOCUMENT 0001127602-24-018078 4741
2024-06-06 4 PRIMARY DOCUMENT 0001127602-24-018073 4749
2024-06-06 4 PRIMARY DOCUMENT 0001127602-24-018068 4740
2024-06-06 4 PRIMARY DOCUMENT 0001127602-24-018063 5813
2024-06-06 4 PRIMARY DOCUMENT 0001127602-24-018059 4683
2024-06-06 4 PRIMARY DOCUMENT 0001127602-24-018056 4625
2024-06-06 4 PRIMARY DOCUMENT 0001127602-24-018053 4650
2024-06-06 4 PRIMARY DOCUMENT 0001127602-24-018051 4673
2024-06-06 4 PRIMARY DOCUMENT 0001127602-24-018049 4675
2024-06-06 8-K 8-K 5.02,5.07 0000950170-24-069899 001-09321 241025222 34 193319 1 1
2024-06-06 4 PRIMARY DOCUMENT 0001127602-24-018041 4682
2024-05-09 4 PRIMARY DOCUMENT 0001127602-24-014797 4885
2024-05-08 10-Q 10-Q 0000950170-24-055718 001-09321 24926497 34 6909914 1 1
2024-04-30 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-04-30 09:30:00 9999999995-24-001219 333-278730 24899785 33 1835
2024-04-26 4 PRIMARY DOCUMENT 0001127602-24-013448 6048
2024-04-25 CORRESP filename1.htm 0001193125-24-113386 5947
2024-04-24 8-K 8-K 2.02,9.01 0000950170-24-047606 001-09321 24870861 34 439081 1 1
2024-04-23 ARS ARS 0000950170-24-046633 001-09321 24862643 34 884439
2024-04-23 DEFA14A DEFA14A 0000950170-24-046631 001-09321 24862639 34 4665840
2024-04-23 DEF 14A DEF 14A 0001193125-24-105818 001-09321 24862631 34 4125303 1 1
2024-04-22 UPLOAD filename1.pdf 0000000000-24-004404 333-278730 40535
2024-04-16 S-3 S-3 0001193125-24-097760 333-278730 24848024 33 1032314
2024-02-27 8-K 8-K 2.02,9.01 0000950170-24-021213 001-09321 24687202 34 593603 1 1
2024-02-27 10-K 10-K 0000950170-24-021191 001-09321 24687097 34 16267165 1 1
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-022187 005-37839 24629754 34 13191
2024-01-29 SC 13G/A Universal_Health_Realty.txt 0000093751-24-000300 005-37839 24570978 34 8652
2024-01-22 SC 13G/A us91359e1055_012224.txt 0001086364-24-000875 005-37839 24548213 34 13617
2023-11-08 10-Q 10-Q 0000950170-23-061157 001-09321 231388192 34 8978862 1 1
2023-10-25 8-K 8-K 2.02,9.01 0000950170-23-055221 001-09321 231346375 34 719485 1 1
2023-08-08 10-Q 10-Q 0000950170-23-039868 001-09321 231151773 34 9749358 1 1
2023-07-25 8-K 8-K 2.02,9.01 0000950170-23-034455 001-09321 231109111 34 814781 1 1
2023-06-08 4 PRIMARY DOCUMENT 0001127602-23-018303 4646
2023-06-08 4 PRIMARY DOCUMENT 0001127602-23-018292 4654
2023-06-08 4 PRIMARY DOCUMENT 0001127602-23-018285 4645
2023-06-08 4 PRIMARY DOCUMENT 0001127602-23-018278 5718
2023-06-08 4 PRIMARY DOCUMENT 0001127602-23-018272 4587
2023-06-08 4 PRIMARY DOCUMENT 0001127602-23-018270 4530
2023-06-08 4 PRIMARY DOCUMENT 0001127602-23-018268 4605
2023-06-08 4 PRIMARY DOCUMENT 0001127602-23-018266 4578
2023-06-08 8-K 8-K 5.02,5.07 0000950170-23-027006 001-09321 231001994 34 230024 1 1
2023-06-08 4 PRIMARY DOCUMENT 0001127602-23-018263 4580
2023-06-08 4 PRIMARY DOCUMENT 0001127602-23-018260 4587
2023-05-17 UPLOAD filename1.pdf 0000000000-23-005264 39851
2023-05-16 8-K 8-K 1.01,2.03,9.01 0000950170-23-022481 001-09321 23927954 34 2569619 1 1
2023-05-16 CORRESP filename1.htm 0000950170-23-022362 18110
2023-05-15 UPLOAD filename1.pdf 0000000000-23-005168 43123
2023-05-09 10-Q 10-Q 0000950170-23-019195 001-09321 23900245 34 8124397 1 1
2023-05-04 CORRESP filename1.htm 0000950170-23-017813 86903
2023-05-03 4 PRIMARY DOCUMENT 0001127602-23-014237 5512
2023-04-25 8-K 8-K 2.02,9.01 0000950170-23-014481 001-09321 23845489 34 616713 1 1
2023-04-25 DEFA14A DEFA14A 0000950170-23-014225 001-09321 23841589 34 875419
2023-04-25 ARS ARS 0000950170-23-014224 001-09321 23841588 34 892559
2023-04-25 DEF 14A DEF 14A 0001193125-23-113887 001-09321 23841577 34 5038549 1 1
2023-04-21 UPLOAD filename1.pdf 0000000000-23-004018 46255
2023-03-10 4 PRIMARY DOCUMENT 0001127602-23-009757 4378
2023-03-08 4 PRIMARY DOCUMENT 0001127602-23-009456 5480
2023-02-27 8-K 8-K 2.02,9.01 0000950170-23-004677 001-09321 23675549 34 856361 1 1
2023-02-27 10-K 10-K 0000950170-23-004655 001-09321 23675121 34 20232370 1 1
2023-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-23-017192 005-37839 23604517 34 13079
2023-02-07 SC 13G/A Univ_Health_Re_Inc_Trust.txt 0000093751-23-000284 005-37839 23593464 34 8577
2023-01-24 SC 13G us91359e1055_012423.txt 0001306550-23-003075 005-37839 23547455 34 13338
2022-12-01 4 PRIMARY DOCUMENT 0001127602-22-026631 4555
2022-12-01 8-K 8-K - REBECCA GUZMAN ANNOUNCEMENT 5.02 0001564590-22-038816 001-09321 221438992 34 163523 1 1
2022-11-30 3 PRIMARY DOCUMENT 0001127602-22-026518 2811
2022-11-08 10-Q 10-Q UHT Q3-2022 0001564590-22-037037 001-09321 221368889 34 8561781 1 1
2022-10-25 8-K UHT 8-K 09-30-2022 2.02,9.01 0001564590-22-035131 001-09321 221330035 34 770995 1 1
2022-09-15 4 PRIMARY DOCUMENT 0001127602-22-022427 5485
2022-09-09 4 PRIMARY DOCUMENT 0001127602-22-022226 5485
2022-09-09 4 PRIMARY DOCUMENT 0001127602-22-022224 4614
2022-08-23 3 PRIMARY DOCUMENT 0001127602-22-021459 2868
2022-08-08 10-Q 10-Q JUNE 30, 2022 0001564590-22-028444 001-09321 221144581 34 8499720 1 1
2022-07-25 8-K 8-K 06-30-2022 2.02,9.01 0001564590-22-026321 001-09321 221103716 34 787443 1 1
2022-06-10 4 PRIMARY DOCUMENT 0001127602-22-017213 4516
2022-06-10 4 PRIMARY DOCUMENT 0001127602-22-017211 4507
2022-06-10 4 PRIMARY DOCUMENT 0001127602-22-017208 5686
2022-06-10 4 PRIMARY DOCUMENT 0001127602-22-017206 4498
2022-06-10 4 PRIMARY DOCUMENT 0001127602-22-017204 4573
2022-06-10 4 PRIMARY DOCUMENT 0001127602-22-017202 4546
2022-06-10 4 PRIMARY DOCUMENT 0001127602-22-017200 4548
2022-06-10 4 PRIMARY DOCUMENT 0001127602-22-017198 4555
2022-06-09 8-K 8-K - PROXY VOTES AND ITEM 5.02 5.07 0001564590-22-022872 001-09321 221006156 34 180741 1 1
2022-05-12 4 PRIMARY DOCUMENT 0001127602-22-014226 6092
2022-05-06 10-Q 10-Q 3-31-2022 0001564590-22-018568 001-09321 22900917 34 7622342 1 1
2022-04-26 DEFA14A DEFA14A 0001193125-22-118724 001-09321 22851677 34 646288
2022-04-26 DEF 14A DEF 14A 0001193125-22-118718 001-09321 22851672 34 2220522
2022-04-25 8-K 8-K 2.02,9.01 0001564590-22-015433 001-09321 22850092 34 561618 1 1
2022-02-24 8-K 8-K 2.02,9.01 0001564590-22-006768 001-09321 22672522 34 804230 1 1
2022-02-24 10-K 10-K 0001564590-22-006745 001-09321 22671951 34 20262921 1 1
2022-02-10 SC 13G UNIV_HEALTH_REALTY_INC_TRUST.txt 0000093751-22-000165 005-37839 22614882 34 8570
2022-02-10 SC 13G/A SCHEDULE 13G/A 0001104659-22-018796 005-37839 22611080 34 13074
2022-01-27 SC 13G/A us91359e1055_012722.txt 0000834237-22-002036 005-37839 22561284 34 13380
2022-01-25 SC 13G/A us91359e1055_012522.txt 0000834237-22-000552 005-37839 22553494 34 13380
2022-01-04 8-K 8-K UHH/UHT ASSET EXCHANGE 12-31-2021 1.01,2.01,9.01 0001564590-22-000291 001-09321 22506092 34 1095034 1 1
2021-11-08 10-Q 10-Q 9-30-2021 0001564590-21-055256 001-09321 211388165 34 8170689 1 1
2021-10-25 8-K 8-K 9/30/2021 2.02,9.01 0001564590-21-051728 001-09321 211344497 34 769235 1 1
2021-09-10 4 PRIMARY DOCUMENT 0001127602-21-025116 5918
2021-08-18 4 PRIMARY DOCUMENT 0001127602-21-023965 5924
2021-08-06 10-Q 10-Q 0001564590-21-042154 001-09321 211153177 34 7972878 1 1
2021-07-26 8-K 8-K 2.02,9.01 0001564590-21-037954 001-09321 211114446 34 790790 1 1
2021-07-08 8-K 8-K 1.01,2.03,9.01 0001564590-21-036033 001-09321 211079035 34 1738714 1 1
2021-06-03 4 PRIMARY DOCUMENT 0001127602-21-018927 4515
2021-06-03 4 PRIMARY DOCUMENT 0001127602-21-018925 4515
2021-06-03 4 PRIMARY DOCUMENT 0001127602-21-018921 4499
2021-06-03 4 PRIMARY DOCUMENT 0001127602-21-018918 5685
2021-06-03 4 PRIMARY DOCUMENT 0001127602-21-018914 4497
2021-06-03 4 PRIMARY DOCUMENT 0001127602-21-018910 4545
2021-06-03 4 PRIMARY DOCUMENT 0001127602-21-018905 4572
2021-06-03 4 PRIMARY DOCUMENT 0001127602-21-018902 4542
2021-06-03 4 PRIMARY DOCUMENT 0001127602-21-018900 4554
2021-06-03 8-K 8-K 2021 VOTES 5.07 0001564590-21-031463 001-09321 21991180 34 186035 1 1
2021-05-07 10-Q 10-Q 0001564590-21-025570 001-09321 21902907 34 6652805 1 1
2021-04-26 8-K 8-K 2.02,9.01 0001564590-21-020544 001-09321 21854153 34 504814 1 1
2021-04-20 DEFA14A DEFA14A 0001564590-21-019499 001-09321 21836229 34 719064
2021-04-20 DEF 14A DEF 14A 0001564590-21-019496 001-09321 21836221 34 3647649
2021-02-25 8-K 8-K 2.02,9.01 0001564590-21-008893 001-09321 21680961 34 789431 1 1
2021-02-25 10-K 10-K 0001564590-21-008850 001-09321 21680564 34 19402234 1 1
2021-02-10 SC 13G/A SCHEDULE 13G/A 0001104659-21-019314 005-37839 21612250 34 13942
2021-01-25 SC 13G us91359e1055_012521.txt 0000834237-21-000406 005-37839 21550247 34 13352
2020-11-06 10-Q 10-Q 0001564590-20-051999 001-09321 201294864 34 8044726 1 1
2020-10-29 8-K 8-K 2.02,9.01 0001564590-20-048888 001-09321 201272996 34 779138 1 1
2020-09-10 4 PRIMARY DOCUMENT 0001127602-20-024879 4214
2020-08-14 S-8 S-8 0001564590-20-040161 333-246042 201101248 33 106503
2020-08-07 10-Q 10-Q 0001564590-20-038417 001-09321 201086066 34 7856929 1 1
2020-07-31 4 PRIMARY DOCUMENT 0001127602-20-022374 5919
2020-07-30 4 PRIMARY DOCUMENT 0001127602-20-022290 4817
2020-07-27 8-K 8-K 2.02,9.01 0001564590-20-033590 001-09321 201050732 34 772382 1 1
2020-06-15 4 PRIMARY DOCUMENT 0001127602-20-019546 4213
2020-06-15 4 PRIMARY DOCUMENT 0001127602-20-019544 4213
2020-06-15 4 PRIMARY DOCUMENT 0001127602-20-019542 4197
2020-06-09 8-K 8-K ATM SALES AGREEMENT 1.01,9.01 0001564590-20-028667 001-09321 20950543 34 914487 1 1
2020-06-09 424B5 424B5 0001564590-20-028666 333-238301 20950524 33 932736
2020-06-05 8-K 8-K 1.01,2.03,5.07,9.01 0001564590-20-028494 001-09321 20946484 34 2612922 1 1
2020-06-04 4 PRIMARY DOCUMENT 0001127602-20-018868 4496
2020-06-04 4 PRIMARY DOCUMENT 0001127602-20-018865 4572
2020-06-04 4 PRIMARY DOCUMENT 0001127602-20-018862 4545
2020-06-04 4 PRIMARY DOCUMENT 0001127602-20-018858 4542
2020-06-04 4 PRIMARY DOCUMENT 0001127602-20-018856 4539
2020-06-04 4 PRIMARY DOCUMENT 0001127602-20-018851 4515
2020-06-04 4 PRIMARY DOCUMENT 0001127602-20-018844 4515
2020-06-04 4 PRIMARY DOCUMENT 0001127602-20-018840 4499
2020-06-04 4 PRIMARY DOCUMENT 0001127602-20-018837 5685
2020-05-15 S-3ASR S-3ASR 0001564590-20-025830 333-238301 20885465 33 842627
2020-05-08 10-Q 10-Q 0001564590-20-023582 001-09321 20860893 34 6447585 1 1
2020-04-27 8-K 8-K 2.02,9.01 0001564590-20-018844 001-09321 20820546 34 611337 1 1
2020-04-21 DEFA14A DEFA14A 0001564590-20-017583 001-09321 20804144 34 278547
2020-04-21 DEF 14A DEF 14A 0001564590-20-017552 001-09321 20803913 34 2124627
2020-02-26 10-K 10-K 0001564590-20-006816 001-09321 20656282 34 18733704 1 1
2020-02-26 8-K 8-K 2.02,9.01 0001564590-20-006813 001-09321 20656215 34 807685 1 1
2020-02-11 SC 13G/A SCHEDULE 13G/A 0001104659-20-016548 005-37839 20597606 34 13765
2020-02-04 SC 13G/A us91359e1055_020320.txt 0000834237-20-002752 005-37839 20572219 34 13362
2019-11-08 10-Q 10-Q 0001564590-19-042274 001-09321 191204355 34 7480104 1 1
2019-10-25 8-K 8-K 2.02,9.01 0001564590-19-037833 001-09321 191167449 34 785253 1 1
2019-08-08 10-Q 10-Q 0001564590-19-030799 001-09321 191009761 34 7277510 1 1
2019-07-26 8-K 8-K 2.02,9.01 0001564590-19-026237 001-09321 19975873 34 774370 1 1
2019-06-13 4 PRIMARY DOCUMENT 0001127602-19-021529 4515
2019-06-13 4 PRIMARY DOCUMENT 0001127602-19-021527 4515
2019-06-13 4 PRIMARY DOCUMENT 0001127602-19-021525 4499
2019-06-13 4 PRIMARY DOCUMENT 0001127602-19-021523 5685
2019-06-13 4 PRIMARY DOCUMENT 0001127602-19-021521 4496
2019-06-13 4 PRIMARY DOCUMENT 0001127602-19-021519 4538
2019-06-13 4 PRIMARY DOCUMENT 0001127602-19-021517 4541
2019-06-13 4 PRIMARY DOCUMENT 0001127602-19-021515 4545
2019-06-13 4 PRIMARY DOCUMENT 0001127602-19-021513 4611
2019-06-12 8-K 8-K 5.07 0001564590-19-022338 001-09321 19893741 34 50376
2019-06-07 4 PRIMARY DOCUMENT 0001127602-19-021102 5388
2019-06-07 4 PRIMARY DOCUMENT 0001127602-19-021100 4213
2019-06-07 4 PRIMARY DOCUMENT 0001127602-19-021098 4197
2019-05-08 10-Q 10-Q 0001564590-19-017209 001-09321 19806809 34 5355050 1
2019-04-26 8-K 8-K 2.02,9.01 0001564590-19-013192 001-09321 19769254 34 414106
2019-04-25 DEFA14A DEFA14A 0001564590-19-012868 001-09321 19765193 34 271843
2019-04-25 DEF 14A DEF 14A 0001564590-19-012866 001-09321 19765183 34 1274379
2019-02-28 8-K 8-K 2.02,9.01 0001564590-19-005156 001-09321 19640330 34 643680
2019-02-27 10-K 10-K 0001564590-19-004923 001-09321 19638116 34 16764026 1
2019-02-11 SC 13G/A universalhealthrealtyincomet.htm 0000932471-19-004557 005-37839 19582567 34 34394
2019-01-31 SC 13G/A universalhealthrealtyincomet.htm 0000932471-19-002323 005-37839 19556239 34 19457
2019-01-31 SC 13G/A us91359e1055_013119.txt 0000215457-19-002716 005-37839 19555476 34 13392
2018-11-08 10-Q 10-Q 0001564590-18-028574 001-09321 181169983 34 4732328 1
2018-10-26 8-K 8-K 2.02,9.01 0001564590-18-025204 001-09321 181140241 34 648581
2018-08-08 10-Q 10-Q 0001564590-18-020497 001-09321 181001659 34 4856589 1
2018-07-26 8-K 8-K 2.02,9.01 0001564590-18-017617 001-09321 18971998 34 630279
2018-07-23 3 PRIMARY DOCUMENT 0001127602-18-023692 4677
2018-07-17 UPLOAD filename1.pdf 0000000000-18-021921 35775
2018-07-17 8-K 8-K - JAMES MOREY - NEW TRUSTEE 5.02 0001564590-18-016890 001-09321 18955485 34 31208
2018-07-11 CORRESP filename1.htm 0001564590-18-016736 29982
2018-06-27 UPLOAD filename1.pdf 0000000000-18-019810 137589
2018-06-14 4 PRIMARY DOCUMENT 0001127602-18-020922 4648
2018-06-14 4 PRIMARY DOCUMENT 0001127602-18-020920 4582
2018-06-14 4 PRIMARY DOCUMENT 0001127602-18-020917 4541
2018-06-14 4 PRIMARY DOCUMENT 0001127602-18-020915 4538
2018-06-14 4 PRIMARY DOCUMENT 0001127602-18-020913 4515
2018-06-14 4 PRIMARY DOCUMENT 0001127602-18-020911 4515
2018-06-14 4 PRIMARY DOCUMENT 0001127602-18-020904 4499
2018-06-14 4 PRIMARY DOCUMENT 0001127602-18-020899 5732
2018-06-13 8-K 8-K ITEM 5.07 5.07 0001564590-18-015541 001-09321 18896875 34 46980
2018-06-12 4 PRIMARY DOCUMENT 0001127602-18-020677 4213
2018-06-12 4 PRIMARY DOCUMENT 0001127602-18-020675 4197
2018-05-09 10-Q 10-Q 0001564590-18-012426 001-09321 18818508 34 4450820 1
2018-04-26 8-K 8-K 2.02,9.01 0001564590-18-009181 001-09321 18776239 34 428620
2018-04-26 DEFA14A DEFA14A 0001564590-18-009156 001-09321 18775964 34 302920
2018-04-26 DEF 14A DEF 14A 0001564590-18-009149 001-09321 18775940 34 1254352
2018-03-29 8-K 8-K 1.01,1.02,2.03,9.01 0001193125-18-101891 001-09321 18722913 34 907723
2018-03-22 8-K FORM 8-K 5.02 0001193125-18-092119 001-09321 18707133 34 15235
2018-03-14 3 PRIMARY DOCUMENT 0001127602-18-011507 2816
2018-03-08 8-K FORM 8-K 5.02 0001193125-18-075122 001-09321 18676531 34 16497
2018-03-01 8-K 8-K 2.02,9.01 0001564590-18-003953 001-09321 18654625 34 729589
2018-02-28 10-K 10-K 0001564590-18-003812 001-09321 18651527 34 16869951 1
2018-02-09 SC 13G/A universalhealthrealtyincomet.htm 0000932471-18-003957 005-37839 18589994 34 45510
2018-02-02 SC 13G/A universalhealthrealtyincomet.htm 0000932471-18-000839 005-37839 18569425 34 44331
2018-01-19 SC 13G/A us91359e1055_011718.txt 0000215457-18-001223 005-37839 18536418 34 13581
2017-12-11 3 PRIMARY DOCUMENT 0001127602-17-034298 4609
2017-11-22 4 PRIMARY DOCUMENT 0001127602-17-033108 4742
2017-11-08 10-Q UHT-10Q-20170930 0001564590-17-022781 001-09321 171187017 34 5285319 1
2017-10-26 8-K UHT-8-K-2017-0930 2.02,9.01 0001564590-17-020193 001-09321 171156729 34 700916
2017-09-12 8-K FORM 8-K 5.02,9.01 0001193125-17-282736 001-09321 171081168 34 15463
2017-08-08 10-Q 10-Q 0001564590-17-016564 001-09321 171015236 34 5012029 1
2017-07-26 8-K 8-K 2.02,9.01 0001564590-17-014073 001-09321 17983273 34 581338 1 1
2017-06-08 8-K 8-K 5.07 0001193125-17-198084 001-09321 17899468 34 25408
2017-06-07 4 PRIMARY DOCUMENT 0001127602-17-020775 4489
2017-06-07 4 PRIMARY DOCUMENT 0001127602-17-020773 4648
2017-06-07 4 PRIMARY DOCUMENT 0001127602-17-020771 4582
2017-06-07 4 PRIMARY DOCUMENT 0001127602-17-020767 4544
2017-06-07 4 PRIMARY DOCUMENT 0001127602-17-020765 4515
2017-06-07 4 PRIMARY DOCUMENT 0001127602-17-020762 5954
2017-06-07 4 PRIMARY DOCUMENT 0001127602-17-020760 5938
2017-06-07 4 PRIMARY DOCUMENT 0001127602-17-020758 7172
2017-05-09 SC 13G/A univ.health.real.txt 0000215457-17-003136 005-37839 17824996 34 13411
2017-05-08 10-Q 10-Q 0001564590-17-009397 001-09321 17822440 34 4657683 1
2017-04-26 8-K 8-K 2.02,9.01 0001564590-17-007299 001-09321 17784810 34 408572
2017-04-20 DEFA14A DEFA14A 0001193125-17-129603 001-09321 17771308 34 179357
2017-04-20 DEF 14A DEF 14A 0001193125-17-129593 001-09321 17771302 34 484808
2017-03-01 8-K 8-K 2.02,9.01 0001564590-17-003010 001-09321 17651329 34 577985
2017-02-28 10-K UHT-10K-20161231 0001564590-17-002865 001-09321 17647997 34 17191442 1
2017-02-14 SC 13G/A universalhealthrealtyincomet.htm 0000932471-17-003095 005-37839 17602678 34 43767
2017-02-10 SC 13G/A universalhealthrealtyincomet.htm 0000932471-17-002112 005-37839 17592753 34 48515
2017-01-27 SC 13G/A univ.health.real.txt 0000215457-17-001823 005-37839 17550979 34 13420
2017-01-24 8-K 8-K 5.02 0001193125-17-016775 001-09321 17544201 34 12716
2016-11-28 UPLOAD filename1.pdf 0000000000-16-102410 33408
2016-11-18 CORRESP filename1.htm 0001193125-16-771599 11467
2016-11-08 10-Q 10-Q 0001564590-16-028351 001-09321 161981569 34 4943683 1
2016-11-01 UPLOAD filename1.pdf 0000000000-16-099234 136265
2016-10-27 8-K 8-K 2.02,9.01 0001564590-16-026390 001-09321 161956075 34 583387
2016-10-03 8-K 8-K 5.03,9.01 0001193125-16-729282 001-09321 161915778 34 155003
2016-08-05 10-Q 10-Q 0001564590-16-022886 001-09321 161809765 34 4873006 1
2016-08-03 4 PRIMARY DOCUMENT 0001127602-16-059395 8087
2016-08-01 4 PRIMARY DOCUMENT 0001127602-16-059045 9332
2016-08-01 4 PRIMARY DOCUMENT 0001127602-16-059043 8112
2016-08-01 4 PRIMARY DOCUMENT 0001127602-16-059040 8124
2016-08-01 4 PRIMARY DOCUMENT 0001127602-16-059038 8111
2016-07-27 8-K 8-K 2.02,9.01 0001193125-16-660030 001-09321 161787041 34 138253
2016-06-13 4 PRIMARY DOCUMENT 0001127602-16-055418 4503
2016-06-13 4 PRIMARY DOCUMENT 0001127602-16-055416 4500
2016-06-13 4 PRIMARY DOCUMENT 0001127602-16-055414 4516
2016-06-13 4 PRIMARY DOCUMENT 0001127602-16-055412 5733
2016-06-13 4 PRIMARY DOCUMENT 0001127602-16-055410 4649
2016-06-13 4 PRIMARY DOCUMENT 0001127602-16-055408 4490
2016-06-13 4 PRIMARY DOCUMENT 0001127602-16-055405 4583
2016-06-13 4 PRIMARY DOCUMENT 0001127602-16-055402 4545
2016-06-13 4 PRIMARY DOCUMENT 0001127602-16-055400 4483
2016-06-10 8-K FORM 8-K 5.07 0001193125-16-618527 001-09321 161707492 34 26091
2016-06-07 S-8 FORM S-8 0001193125-16-615334 333-211903 161701594 33 78949
2016-05-25 8-K 8-K 1.01,9.01 0001193125-16-601831 001-09321 161673970 34 86731
2016-05-23 4 PRIMARY DOCUMENT 0001127602-16-053102 8156
2016-05-17 4 PRIMARY DOCUMENT 0001127602-16-052445 6692
2016-05-06 10-Q 10-Q 0001564590-16-018296 001-09321 161628610 34 4357788 1
2016-05-03 8-K FORM 8-K 1.01,9.01 0001193125-16-575108 001-09321 161616043 34 213392
2016-05-02 424B5 424B5 0001193125-16-571405 333-208264 161609958 33 277097
2016-05-02 8-K FORM 8-K 8.01 0001193125-16-571391 001-09321 161609906 34 93157
2016-04-28 8-K 8-K 2.02,9.01 0001564590-16-016985 001-09321 161600773 34 414924 1
2016-04-22 DEFA14A DEFA14A 0001193125-16-551165 001-09321 161585248 34 202250
2016-04-22 DEF 14A DEF 14A 0001193125-16-551150 001-09321 161585243 34 776161
2016-03-04 10-K 10-K 0001564590-16-014024 001-09321 161483503 34 16914699 1
2016-02-29 8-K 8-K 2.02,9.01 0001564590-16-013734 001-09321 161468237 34 687977
2016-02-11 SC 13G/A universalhealthrealtyinctrst.htm 0000932471-16-011908 005-37839 161408042 34 39824
2016-02-09 SC 13G/A universalhealthpropincome_am.htm 0000932471-16-010426 005-37839 161397451 34 36401
2016-01-27 SC 13G/A univ.health.real.2015.txt 0000215457-16-004108 005-37839 161364994 34 13388
2015-12-22 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2015-12-22 16:00:00 9999999995-15-003365 333-208264 151304153 33 1774
2015-12-18 CORRESP filename1.htm 0001193125-15-407920 8313
2015-12-14 UPLOAD filename1.pdf 0000000000-15-057705 155736
2015-11-30 S-3 FORM S-3 0001193125-15-390709 333-208264 151260072 33 1198440
2015-11-06 10-Q 10-Q 0001564590-15-009819 001-09321 151202390 34 5429145 1
2015-10-28 8-K 8-K 2.02,9.01 0001564590-15-008761 001-09321 151180868 34 665491
2015-09-10 4 PRIMARY DOCUMENT 0001127602-15-026815 4316
2015-08-25 4 PRIMARY DOCUMENT 0001127602-15-025777 6689
2015-08-25 4 PRIMARY DOCUMENT 0001127602-15-025776 7906
2015-08-25 4 PRIMARY DOCUMENT 0001127602-15-025775 6674
2015-08-12 4 PRIMARY DOCUMENT 0001127602-15-024786 8116
2015-08-07 10-Q UNIVERSAL HEALTH REALTY INCOME TRUST--FORM 10-Q 0001193125-15-281885 001-09321 151034877 34 3347174 1
2015-07-29 8-K UNIVERSAL HEALTH REALTY INCOME TRUST--FORM 8-K 2.02,9.01 0001193125-15-268482 001-09321 151013606 34 141367
2015-06-05 4 PRIMARY DOCUMENT 0001127602-15-019917 4457
2015-06-05 4 PRIMARY DOCUMENT 0001127602-15-019916 4474
2015-06-05 4 PRIMARY DOCUMENT 0001127602-15-019915 4519
2015-06-05 4 PRIMARY DOCUMENT 0001127602-15-019914 4477
2015-06-05 4 PRIMARY DOCUMENT 0001127602-15-019913 5707
2015-06-05 4 PRIMARY DOCUMENT 0001127602-15-019912 4622
2015-06-05 4 PRIMARY DOCUMENT 0001127602-15-019911 4557
2015-06-05 4 PRIMARY DOCUMENT 0001127602-15-019910 4490
2015-06-05 4 PRIMARY DOCUMENT 0001127602-15-019907 4464
2015-06-05 8-K UNIVERSAL HEALTH REALTY INCOME TRUST--FORM 8-K 5.07 0001193125-15-214232 001-09321 15914557 34 20428
2015-05-08 10-Q UNIVERSAL HEALTH REALTY INCOME TRUST--FORM 10-Q 0001193125-15-178211 001-09321 15844376 34 4098306 1
2015-04-28 8-K UHT-FORM 8-K 2.02,9.01 0001193125-15-153217 001-09321 15799517 34 100120
2015-04-27 ARS AUTO-GENERATED PAPER DOCUMENT 9999999997-15-009363 001-09321 15007111 34 1393
2015-04-24 DEFA14A UNIVERSAL HEALTH REALTY INCOME TRUST--DEFINITIVE ADDITIONAL MATERIALS 0001193125-15-145172 001-09321 15789931 34 222256
2015-04-24 DEF 14A UNIVERSAL HEALTH REALTY INCOME TRUST - DEF14A 0001193125-15-145167 001-09321 15789928 34 597017
2015-03-31 8-K FORM 8-K 1.01,1.02,2.03,9.01 0001193125-15-114378 001-09321 15740192 34 811671
2015-03-06 10-K UNIVERSAL HEALTH REALTY INCOME TRUST--FORM 10-K 0001193125-15-079092 001-09321 15678550 34 13096585 1
2015-02-25 8-K UNIVERSAL HEALTH REALTY INCOME TRUST--FORM 8-K 2.02,9.01 0001193125-15-062812 001-09321 15648890 34 165781
2015-02-11 SC 13G/A universalhealthrealtyincome.htm 0000932471-15-004744 005-37839 15596748 34 39820
2015-02-06 SC 13G/A universalhealthrealtyincomet.htm 0000932471-15-003238 005-37839 15583070 34 35781
2015-01-15 SC 13G/A universal.health.realty.txt 0001086364-15-000390 005-37839 15529769 34 13321
2014-11-14 3 PRIMARY DOCUMENT 0001127602-14-032240 3537
2014-11-07 10-Q UNIVERSAL HEALTH REALTY INCOME TRUST--FORM 10-Q 0001193125-14-402048 001-09321 141202611 34 4634725 1
2014-10-29 8-K UNIVERSAL HEALTH REALTY INCOME TRUST--FORM 8-K 8.01 0001193125-14-386315 001-09321 141178834 34 152096
2014-10-24 8-K UNIVERSAL HEALTH REALTY INCOME TRUST--FORM 8-K 2.02,9.01 0001193125-14-380889 001-09321 141171177 34 169866
2014-08-08 10-Q UNIVERSAL HEALTH REALTY INCOME TRUST--FORM 10-Q 0001193125-14-301633 001-09321 141025531 34 4274115 1
2014-08-01 4 PRIMARY DOCUMENT 0001127602-14-024397 8157
2014-07-23 8-K UNIVERSAL HEALTH REALTY INCOME TRUST--FORM 8-K 2.02,9.01 0001193125-14-277182 001-09321 14989206 34 146590
2014-06-13 4 PRIMARY DOCUMENT 0001127602-14-020782 4457
2014-06-13 4 PRIMARY DOCUMENT 0001127602-14-020781 4519
2014-06-13 4 PRIMARY DOCUMENT 0001127602-14-020780 4557
2014-06-13 4 PRIMARY DOCUMENT 0001127602-14-020778 4464
2014-06-13 4 PRIMARY DOCUMENT 0001127602-14-020777 5707
2014-06-13 4 PRIMARY DOCUMENT 0001127602-14-020776 4474
2014-06-13 4 PRIMARY DOCUMENT 0001127602-14-020775 4490
2014-06-13 4 PRIMARY DOCUMENT 0001127602-14-020774 4477
2014-06-13 4 PRIMARY DOCUMENT 0001127602-14-020773 4622
2014-06-12 8-K UNIVERSAL HEALTH REALTY INCOME TRUST--FORM 8-K 5.07 0001193125-14-234773 001-09321 14907184 34 20863
2014-06-02 4 PRIMARY DOCUMENT 0001127602-14-019332 8094
2014-05-07 10-Q UNIVERSAL HEALTH REALTY INCOME TRUST--FORM 10-Q 0001193125-14-187482 001-09321 14821139 34 3891966 1
2014-05-05 ARS AUTO-GENERATED PAPER DOCUMENT 9999999997-14-009893 001-09321 14007279 34 1393
2014-04-29 DEFA14A UNIVERSAL HEALTH REALTY INCOME TRUST--DEFA14A 0001193125-14-164872 001-09321 14791222 34 212910
2014-04-29 DEF 14A UNIVERSAL HEALTH REALTY INCOME TRUST--DEF 14A 0001193125-14-164861 001-09321 14791218 34 691200
2014-04-23 8-K FORM 8-K 2.02,9.01 0001193125-14-155039 001-09321 14779470 34 108750
2014-03-12 4 PRIMARY DOCUMENT 0001127602-14-011221 6663
2014-03-07 10-K UNIVERSAL HEALTH REALTY INCOME TRUST--10-K 0001193125-14-087617 001-09321 14675004 34 11968681 1
2014-02-26 8-K FORM 8-K 2.02,9.01 0001193125-14-070041 001-09321 14645784 34 150959
2014-02-12 SC 13G/A universalhealthrealtyincome.htm 0000932471-14-004193 005-37839 14598006 34 52013
2014-02-04 SC 13G/A universalhealthrealtyincomet.htm 0000932471-14-002427 005-37839 14571599 34 35301

Latest XBRL company facts

One latest value per concept from companyfacts (322 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 13.90M 2026-10-31 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
dei EntityPublicFloat Entity Public Float USD 512.90M 2025-06-30 2025 FY 10-K 2026-02-25 0001193125-26-071594
ecd CoSelectedMeasureAmt CoSelectedMeasureAmt USD 47.69M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001193125-26-183412
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 153,141 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001193125-26-183412
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 127,048 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001193125-26-183412
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 209.57 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001193125-26-183412
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 323,950 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001193125-26-183412
ecd PeoTotalCompAmt PeoTotalCompAmt USD 268,766 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001193125-26-183412
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 83.16 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001193125-26-183412
srt RealEstateAndAccumulatedDepreciationAmountOfEncumbrances SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, Amount of Encumbrances USD 18.57M 2025-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
srt RealEstateFederalIncomeTaxBasis SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Federal Income Tax Basis USD 418.00M 2025-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 13.34M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 3.41M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 240.99M 2015-03-31 2015 Q1 10-Q 2015-05-08 0001193125-15-178211
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 272.82M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 12,000 2011-01-01 2011-12-31 2013 FY 10-K 2014-03-07 0001193125-14-087617
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition USD 617,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 0 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-07 0001193125-14-087617
us-gaap AmortizationOfAboveAndBelowMarketLeases Amortization of above and below Market Leases USD -107,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap AmortizationOfAcquiredIntangibleAssets Amortization of Acquired Intangible Assets (Deprecated 2013-01-31) USD 7.80M 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-13 0001193125-13-105230
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD -40,000 2023-01-01 2023-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 629,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 4.90M 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-28 0001564590-18-003812
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 4.60M 2008-01-01 2008-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap Assets Assets USD 573.01M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperation Disposal Group, Including Discontinued Operation, Assets USD 7.37M 2021-09-30 2021 Q3 10-Q 2021-11-08 0001564590-21-055256
us-gaap BusinessAcquisitionCostOfAcquiredEntityPurchasePrice Business Acquisition, Cost of Acquired Entity, Purchase Price (Deprecated 2013-01-31) USD 30.41M 2012-03-31 2013 Q1 10-Q 2013-05-07 0001193125-13-204699
us-gaap BusinessAcquisitionProFormaEarningsPerShareDiluted Business Acquisition, Pro Forma Earnings Per Share, Diluted USD/shares 1.24 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-28 0001564590-17-002865
us-gaap BusinessAcquisitionPurchasePriceAllocationAssetsAcquired Business Acquisition, Purchase Price Allocation, Assets Acquired (Deprecated 2013-01-31) USD 26.81M 2012-09-30 2012 Q3 10-Q 2012-11-08 0001193125-12-458748
us-gaap BusinessAcquisitionPurchasePriceAllocationAssetsAcquiredLiabilitiesAssumedNet Business Acquisition, Purchase Price Allocation, Assets Acquired (Liabilities Assumed), Net (Deprecated 2013-01-31) USD 7.32M 2012-03-31 2013 Q1 10-Q 2013-05-07 0001193125-13-204699
us-gaap BusinessAcquisitionPurchasePriceAllocationLand Business Acquisition, Purchase Price Allocation, Land (Deprecated 2013-01-31) USD 1.90M 2012-03-31 2013 Q1 10-Q 2013-05-07 0001193125-13-204699
us-gaap BusinessAcquisitionPurchasePriceAllocationLiabilitiesAssumed Business Acquisition, Purchase Price Allocation, Liabilities Assumed (Deprecated 2013-01-31) USD 111,000 2012-09-30 2012 Q3 10-Q 2012-11-08 0001193125-12-458748
us-gaap BusinessAcquisitionPurchasePriceAllocationNotesPayableAndLongTermDebt Business Acquisition, Purchase Price Allocation, Notes Payable and Long-term Debt (Deprecated 2013-01-31) USD 22.44M 2012-03-31 2013 Q1 10-Q 2013-05-07 0001193125-13-204699
us-gaap BusinessAcquisitionPurchasePriceAllocationOtherAssets Business Acquisition, Purchase Price Allocation, Other Assets (Deprecated 2013-01-31) USD 799,000 2012-12-31 2012 FY 10-K 2013-03-13 0001193125-13-105230
us-gaap BusinessAcquisitionPurchasePriceAllocationTangibleAssets Business Acquisition, Purchase Price Allocation, Tangible Assets (Deprecated 2013-01-31) USD 34.00M 2012-12-31 2012 FY 10-K 2013-03-13 0001193125-13-105230
us-gaap BusinessAcquisitionsProFormaNetIncomeLoss Business Acquisition, Pro Forma Net Income (Loss) USD 16.70M 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-28 0001564590-17-002865
us-gaap BusinessAcquisitionsProFormaRevenue Business Acquisition, Pro Forma Revenue USD 70.20M 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-28 0001564590-17-002865
us-gaap BusinessCombinationBargainPurchaseGainRecognizedAmount Business Combination, Bargain Purchase, Gain Recognized, Amount USD 25.40M 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-04 0001564590-16-014024
us-gaap BusinessCombinationConsiderationTransferred1 Business Combination, Consideration Transferred USD 9.00M 2017-01-01 2017-12-31 2019 FY 10-K 2020-02-26 0001564590-20-006816
us-gaap BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual USD 474,000 2011-01-01 2011-12-31 2013 FY 10-K 2014-03-07 0001193125-14-087617
us-gaap BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual USD 1.80M 2011-01-01 2011-12-31 2013 FY 10-K 2014-03-07 0001193125-14-087617
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets USD 4.10M 2015-02-28 2016 Q1 10-Q 2016-05-06 0001564590-16-018296
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Buildings USD 39.65M 2016-09-30 2017 Q3 10-Q 2017-11-08 0001564590-17-022781
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles USD 7.09M 2016-09-30 2017 Q3 10-Q 2017-11-08 0001564590-17-022781
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Land USD 6.89M 2016-09-30 2017 Q3 10-Q 2017-11-08 0001564590-17-022781
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities USD 2.30M 2014-08-31 2016 FY 10-K 2017-02-28 0001564590-17-002865
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net USD 52.19M 2016-09-30 2017 Q3 10-Q 2017-11-08 0001564590-17-022781
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt USD 29.80M 2014-12-31 2016 FY 10-K 2017-02-28 0001564590-17-002865
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment USD 84.00M 2014-12-31 2016 FY 10-K 2017-02-28 0001564590-17-002865
us-gaap BusinessCombinationSeparatelyRecognizedTransactionsExpensesAndLossesRecognized Business Combination, Separately Recognized Transactions, Expenses and Losses Recognized USD 134,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-28 0001564590-17-002865
us-gaap BusinessCombinationSeparatelyRecognizedTransactionsRevenuesAndGainsRecognized Business Combination, Separately Recognized Transactions, Revenues and Gains Recognized USD 2.40M 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-28 0001564590-17-002865
us-gaap BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain USD 27.20M 2017-01-01 2017-12-31 2019 FY 10-K 2020-02-26 0001564590-20-006816
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 6.47M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -543,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-28 0001564590-18-003812
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 5.73M 2018-06-30 2018 Q2 10-Q 2018-08-08 0001564590-18-020497
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 6.47M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 822,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012426
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -215,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap CommonStockDividendsPerShareCashPaid Common Stock, Dividends, Per Share, Cash Paid USD/shares 2.245 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap CommonStockDividendsPerShareDeclared Common Stock, Dividends, Per Share, Declared USD/shares 2.065 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-06 0001564590-20-051999
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 95.00M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 13.90M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 13.90M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap CommonStockValue Common Stock, Value, Issued USD 139,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap CompensatingBalanceAmount Compensating Balance, Amount USD 0 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD 17.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest USD 17.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap ConstructionInProgressExpendituresIncurredButNotYetPaid Construction in Progress Expenditures Incurred but Not yet Paid USD 3.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap CostsAndExpenses Costs and Expenses USD 47.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap CumulativeDividends Cumulative Dividends USD 1.02B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap DebtInstrumentInterestRateEffectivePercentage Debt Instrument, Interest Rate, Effective Percentage pure 0.05 2025-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap DebtInstrumentUnamortizedDiscountPremiumNet Debt Instrument, Unamortized Discount (Premium), Net USD 604,000 2014-06-30 2014 Q2 10-Q 2014-08-08 0001193125-14-301633
us-gaap DebtInstrumentUnamortizedPremium Debt Instrument, Unamortized Premium USD 78,000 2022-03-31 2022 Q1 10-Q 2022-05-06 0001564590-22-018568
us-gaap DeferredCostsAndOtherAssets Deferred Costs and Other Assets USD 17.58M 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021191
us-gaap DeferredRentReceivablesNet Deferred Rent Receivables, Net USD 2.56M 2017-03-31 2017 Q1 10-Q 2017-05-08 0001564590-17-009397
us-gaap Depreciation Depreciation USD 26.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 21.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 21.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap Dividends Dividends USD 31.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap DividendsCash Dividends, Cash USD 23.70M 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-11-07 0001193125-13-431369
us-gaap DividendsPayableCurrentAndNoncurrent Dividends Payable USD 9.35M 2019-06-30 2019 Q2 10-Q 2019-08-08 0001564590-19-030799
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares 1.15 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares 0.62 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-08 0001564590-19-030799
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares 1.14 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap EquityMethodInvestmentRealizedGainLossOnDisposal Equity Method Investment, Realized Gain (Loss) on Disposal USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-06 0001193125-15-079092
us-gaap EquityMethodInvestments Equity Method Investments USD 6.66M 2020-03-31 2020 Q1 10-Q 2020-05-08 0001564590-20-023582
us-gaap EquityMethodInvestmentSummarizedFinancialInformationAssets Equity Method Investment, Summarized Financial Information, Assets (Deprecated 2020-01-31) USD 41.84M 2020-03-31 2020 Q1 10-Q 2020-05-08 0001564590-20-023582
us-gaap EquityMethodInvestmentSummarizedFinancialInformationEquity Equity Method Investment Summarized Financial Information, Equity (Deprecated 2020-01-31) USD 8.82M 2020-03-31 2020 Q1 10-Q 2020-05-08 0001564590-20-023582
us-gaap EquityMethodInvestmentSummarizedFinancialInformationLiabilities Equity Method Investment, Summarized Financial Information, Liabilities (Deprecated 2020-01-31) USD 2.69M 2017-09-30 2017 Q3 10-Q 2017-11-08 0001564590-17-022781
us-gaap EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity Equity Method Investment, Summarized Financial Information, Liabilities and Equity (Deprecated 2020-01-31) USD 41.84M 2020-03-31 2020 Q1 10-Q 2020-05-08 0001564590-20-023582
us-gaap EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss Equity Method Investment, Summarized Financial Information, Net Income (Loss) (Deprecated 2020-01-31) USD 728,000 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-08 0001564590-20-023582
us-gaap EquityMethodInvestmentSummarizedFinancialInformationRevenue Equity Method Investment, Summarized Financial Information, Revenue (Deprecated 2020-01-31) USD 2.52M 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-08 0001564590-20-023582
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 10.60M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 3.70M 2017-12-31 2017 FY 10-K 2018-02-28 0001564590-18-003812
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 1.80M 2017-12-31 2017 FY 10-K 2018-02-28 0001564590-18-003812
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 2.50M 2017-12-31 2017 FY 10-K 2018-02-28 0001564590-18-003812
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 2.90M 2017-12-31 2017 FY 10-K 2018-02-28 0001564590-18-003812
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 3.10M 2017-12-31 2017 FY 10-K 2018-02-28 0001564590-18-003812
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 17.40M 2018-12-31 2018 FY 10-K 2019-02-27 0001564590-19-004923
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD -232,000 2023-01-01 2023-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap GainLossOnSaleOfEquityInvestments Gain (Loss) on Sale of Equity Investments USD 316,000 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-08 0001193125-14-301633
us-gaap GainLossOnSaleOfProperties Gain (Loss) on Sale of Properties USD 724,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap GainLossOnSaleOfProperty Gain (Loss) on Disposition of Oil and Gas and Timber Property USD 724,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 8.74M 2015-01-01 2015-12-31 2017 FY 10-K 2018-02-28 0001564590-18-003812
us-gaap GainOnBusinessInterruptionInsuranceRecovery Gain on Business Interruption Insurance Recovery USD 4.54M 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008850
us-gaap GainOnPurchaseOfBusiness Gain on Purchase of Business (Deprecated 2013-01-31) USD 28.58M 2011-01-01 2011-12-31 2012 FY 10-K 2013-03-13 0001193125-13-105230
us-gaap GainsLossesOnSalesOfInvestmentRealEstate Gains (Losses) on Sales of Investment Real Estate USD 1.95M 2019-01-01 2019-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008850
us-gaap IncomeLossBeforeGainOrLossOnSaleOfPropertiesExtraordinaryItemsAndCumulativeEffectsOfAccountingChanges Income (Loss) before Gain (Loss) on Sale of Properties (Deprecated 2020-01-31) USD 18.50M 2018-01-01 2018-12-31 2019 FY 10-K 2020-02-26 0001564590-20-006816
us-gaap IncomeLossFromEquityMethodInvestments Income (Loss) from Equity Method Investments USD 1.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions Income (Loss) from Equity Method Investments, Net of Dividends or Distributions USD 198,000 2015-01-01 2015-06-30 2016 Q2 10-Q 2016-08-05 0001564590-16-022886
us-gaap IncreaseDecreaseInAccruedInterestReceivableNet Increase (Decrease) in Accrued Interest Receivable, Net USD 44,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD -1.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap IncreaseDecreaseInDeferredRentReceivables Increase (Decrease) in Deferred Rent Receivables (Deprecated 2012-01-31) USD 527,000 2012-01-01 2012-03-31 2012 Q1 10-Q 2012-05-08 0001193125-12-218409
us-gaap IncreaseDecreaseInLeasingReceivables Increase (Decrease) in Leasing Receivables USD 699,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap IncreaseDecreaseInOtherOperatingCapitalNet Increase (Decrease) in Other Operating Assets and Liabilities, Net USD 64,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap InsuranceRecoveries Insurance Recoveries USD 4.97M 2017-01-01 2017-12-31 2019 FY 10-K 2020-02-26 0001564590-20-006816
us-gaap InsuranceSettlementsReceivable Insurance Settlements Receivable USD 1.90M 2017-09-30 2017 Q3 10-Q 2017-11-08 0001564590-17-022781
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 4.50M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap InterestAndDebtExpense Interest and Debt Expense USD 108,000 2012-01-01 2012-01-31 2012 Q3 10-Q 2012-11-08 0001193125-12-458748
us-gaap InterestExpense Interest Expense USD 2.17M 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-06 0001564590-16-018296
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD -13.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap InterestIncomeOther Interest Income, Other USD 1.20M 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-28 0001564590-17-002865
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 12.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap InterestPayableCurrentAndNoncurrent Interest Payable USD 866,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap InventoryRealEstateConstructionInProcess Inventory, Real Estate, Construction in Process USD 4.25M 2025-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap InvestmentBuildingAndBuildingImprovements Investment Building and Building Improvements USD 478.40M 2016-03-31 2016 Q1 10-Q 2016-05-06 0001564590-16-018296
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 817,000 2012-01-01 2012-06-30 2012 Q2 10-Q 2012-08-08 0001193125-12-342328
us-gaap InvestmentOwnedAtFairValue Investment Owned, at Fair Value USD 19.66M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap Investments Investments USD 498.86M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap InvestmentsInAndAdvancesToAffiliatesAtFairValue Investments in and Advances to Affiliates, at Fair Value USD 9.60M 2023-03-31 2023 Q1 10-Q 2023-05-09 0000950170-23-019195
us-gaap Land Land USD 56.85M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap LeaseCost Lease, Cost USD 508,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-24 0001564590-22-006745
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 40.89M 2025-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 37.22M 2025-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 718,000 2025-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 737,000 2025-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 737,000 2025-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 737,000 2025-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 737,000 2025-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 120,000 2019-09-30 2019 Q3 10-Q 2019-11-08 0001564590-19-042274
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 29.49M 2025-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap LessorOperatingLeasePaymentsToBeReceived Lessor, Operating Lease, Payments to be Received USD 366.75M 2025-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap LessorOperatingLeasePaymentsToBeReceivedFiveYears Lessor, Operating Lease, Payment to be Received, Year Five USD 30.52M 2025-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap LessorOperatingLeasePaymentsToBeReceivedFourYears Lessor, Operating Lease, Payment to be Received, Year Four USD 39.97M 2025-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths Lessor, Operating Lease, Payment to be Received, Year One USD 75.79M 2025-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap LessorOperatingLeasePaymentsToBeReceivedThereafter Lessor, Operating Lease, Payment to be Received, after Year Five USD 117.19M 2025-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap LessorOperatingLeasePaymentsToBeReceivedThreeYears Lessor, Operating Lease, Payment to be Received, Year Three USD 47.34M 2025-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap LessorOperatingLeasePaymentsToBeReceivedTwoYears Lessor, Operating Lease, Payment to be Received, Year Two USD 55.94M 2025-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap LettersOfCreditOutstandingAmount Letters of Credit Outstanding, Amount USD 425.00M 2025-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap Liabilities Liabilities USD 433.51M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 573.01M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation Disposal Group, Including Discontinued Operation, Liabilities USD 77,000 2021-09-30 2021 Q3 10-Q 2021-11-08 0001564590-21-055256
us-gaap LineOfCredit Long-term Line of Credit USD 377.70M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap LineOfCreditFacilityAmountOutstanding Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) USD 102.40M 2014-06-30 2014 Q2 10-Q 2014-08-08 0001193125-14-301633
us-gaap LineOfCreditFacilityAverageOutstandingAmount Line of Credit Facility, Average Outstanding Amount USD 347.60M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap LineOfCreditFacilityIncreaseAdditionalBorrowings Line of Credit Facility, Increase, Additional Borrowings (Deprecated 2013-01-31) USD 50.00M 2011-07-01 2011-07-25 2012 Q2 10-Q 2012-08-08 0001193125-12-342328
us-gaap LineOfCreditFacilityMaximumBorrowingCapacity Line of Credit Facility, Maximum Borrowing Capacity USD 250.00M 2016-05-31 2016 FY 10-K 2017-02-28 0001564590-17-002865
us-gaap LineOfCreditFacilityRemainingBorrowingCapacity Line of Credit Facility, Remaining Borrowing Capacity USD 97.30M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage Line of Credit Facility, Unused Capacity, Commitment Fee Percentage pure 0.003 2012-06-01 2012-06-30 2012 Q2 10-Q 2012-08-08 0001193125-12-342328
us-gaap LinesOfCreditFairValueDisclosure Lines of Credit, Fair Value Disclosure USD 356.20M 2025-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap LoansPayable Loans Payable USD 6.47M 2011-09-30 2011 Q3 10-Q 2011-11-07 0001193125-11-299513
us-gaap LongTermDebt Long-term Debt USD 374.77M 2025-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap LongTermDebtFairValue Long-term Debt, Fair Value USD 65.40M 2018-09-30 2018 Q3 10-Q 2018-11-08 0001564590-18-028574
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive Long-Term Debt, Maturity, after Year Five USD 9.62M 2025-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 600,000 2025-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive Long-Term Debt, Maturity, Year Five USD 6.39M 2025-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 680,000 2025-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 356.85M 2025-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 626,000 2025-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap MinorityInterest Stockholders' Equity Attributable to Noncontrolling Interest USD 0 2013-12-31 2013 FY 10-K 2014-03-07 0001193125-14-087617
us-gaap MinorityInterestIncreaseFromStockIssuance Noncontrolling Interest, Increase from Equity Issuance or Sale of Parent Equity Interest (Deprecated 2013-01-31) USD 51,000 2009-01-01 2009-12-31 2011 FY 10-K 2012-03-13 0001193125-12-111276
us-gaap MinorityInterestOwnershipPercentageByNoncontrollingOwners Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners pure 0.9 2013-12-31 2013 FY 10-K 2014-03-07 0001193125-14-087617
us-gaap MinorityInterestOwnershipPercentageByParent Noncontrolling Interest, Ownership Percentage by Parent pure 1 2014-12-31 2016 FY 10-K 2017-02-28 0001564590-17-002865
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -10.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD -12.12M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012426
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -23.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD 2.18M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012426
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD 33.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD 10.76M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012426
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD 15.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap NetRentableArea Net Rentable Area sqft 16,000 2015-02-28 2016 Q1 10-Q 2016-05-06 0001564590-16-018296
us-gaap NoncashOrPartNoncashAcquisitionDebtAssumed1 Noncash or Part Noncash Acquisition, Debt Assumed USD 7.50M 2016-01-01 2016-12-31 2018 FY 10-K 2019-02-27 0001564590-19-004923
us-gaap NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1 Noncash or Part Noncash Acquisition, Value of Assets Acquired USD 9.89M 2015-01-01 2015-12-31 2017 FY 10-K 2018-02-28 0001564590-18-003812
us-gaap NoncontrollingInterestDecreaseFromDeconsolidation Noncontrolling Interest, Decrease from Deconsolidation USD 74,000 2013-01-01 2013-12-31 2015 FY 10-K 2016-03-04 0001564590-16-014024
us-gaap NonRecourseDebt Non-Recourse Debt USD 56.62M 2022-03-31 2022 Q1 10-Q 2022-05-06 0001564590-22-018568
us-gaap NotesReceivableGross Financing Receivable, before Allowance for Credit Loss USD 81.53M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap NumberOfBusinessesAcquired Number of Businesses Acquired Acquisition 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap NumberOfPropertiesSubjectToGroundLeases Number of Properties Subject to Ground Leases Property 14 2019-09-30 2019 Q3 10-Q 2019-11-08 0001564590-19-042274
us-gaap NumberOfRealEstateProperties Number of Real Estate Properties Property 62 2015-12-31 2015 FY 10-K 2016-03-04 0001564590-16-014024
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap NumberOfStatesInWhichEntityOperates Number of States in which Entity Operates State 18 2015-12-31 2015 FY 10-K 2016-03-04 0001564590-16-014024
us-gaap OperatingExpenses Operating Expenses USD 6.99M 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-08 0001193125-12-458748
us-gaap OperatingIncomeLoss Operating Income (Loss) USD 27.12M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap OperatingLeaseCost Operating Lease, Cost USD 508,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-24 0001564590-22-006745
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 723,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 11.39M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap OperatingLeasePayments Operating Lease, Payments USD 723,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 11.37M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 27.95M 2018-12-31 2018 FY 10-K 2019-02-27 0001564590-19-004923
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 474,000 2018-12-31 2018 FY 10-K 2019-02-27 0001564590-19-004923
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 474,000 2018-12-31 2018 FY 10-K 2019-02-27 0001564590-19-004923
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 474,000 2018-12-31 2018 FY 10-K 2019-02-27 0001564590-19-004923
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 474,000 2018-12-31 2018 FY 10-K 2019-02-27 0001564590-19-004923
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 474,000 2018-12-31 2018 FY 10-K 2019-02-27 0001564590-19-004923
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 25.58M 2018-12-31 2018 FY 10-K 2019-02-27 0001564590-19-004923
us-gaap OperatingLeasesFutureMinimumPaymentsReceivable Operating Leases, Future Minimum Payments Receivable USD 274.49M 2018-12-31 2019 FY 10-K 2020-02-26 0001564590-20-006816
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableCurrent Operating Leases, Future Minimum Payments Receivable, Current USD 56.49M 2018-12-31 2019 FY 10-K 2020-02-26 0001564590-20-006816
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableInFiveYears Operating Leases, Future Minimum Payments Receivable, in Five Years USD 24.97M 2018-12-31 2019 FY 10-K 2020-02-26 0001564590-20-006816
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableInFourYears Operating Leases, Future Minimum Payments Receivable, in Four Years USD 30.09M 2018-12-31 2019 FY 10-K 2020-02-26 0001564590-20-006816
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears Operating Leases, Future Minimum Payments Receivable, in Three Years USD 45.36M 2018-12-31 2019 FY 10-K 2020-02-26 0001564590-20-006816
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears Operating Leases, Future Minimum Payments Receivable, in Two Years USD 50.29M 2018-12-31 2019 FY 10-K 2020-02-26 0001564590-20-006816
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableRemainderOfFiscalYear Operating Leases, Future Minimum Payments Receivable, Remainder of Fiscal Year USD 14.29M 2019-09-30 2019 Q3 10-Q 2019-11-08 0001564590-19-042274
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableThereafter Operating Leases, Future Minimum Payments Receivable, Thereafter USD 67.29M 2018-12-31 2019 FY 10-K 2020-02-26 0001564590-20-006816
us-gaap OperatingLeasesIncomeStatementMinimumLeaseRevenue Operating Leases, Income Statement, Minimum Lease Revenue USD 4.18M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012426
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.063 2025-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax USD 1.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD 1.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax USD -69,000 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-08 0001564590-16-028351
us-gaap OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax USD -132,000 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-08 0001564590-19-030799
us-gaap OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax USD -82,000 2018-01-01 2018-09-30 2019 Q3 10-Q 2019-11-08 0001564590-19-042274
us-gaap OtherCostAndExpenseOperating Other Cost and Expense, Operating USD 22.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap OtherNonrecurringExpense Other Nonrecurring Expense USD 3.40M 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-08 0001564590-17-022781
us-gaap OtherRealEstateValuationAdjustments Other Real Estate, Valuation Adjustments USD 99.75M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap OwnedPropertyManagementCosts Owned Property Management Costs (Deprecated 2018-01-31) USD 904,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012426
us-gaap PaymentsForAdvanceToAffiliate Payments for Advance to Affiliate USD 22.80M 2015-01-01 2015-12-31 2017 FY 10-K 2018-02-28 0001564590-18-003812
us-gaap PaymentsForDepositsOnRealEstateAcquisitions Payments for Deposits on Real Estate Acquisitions USD 200,000 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-07 0001564590-21-025570
us-gaap PaymentsForProceedsFromDepositsOnRealEstateAcquisitions Payments for (Proceeds from) Deposits on Real Estate Acquisitions USD 150,000 2017-01-01 2017-06-30 2018 Q2 10-Q 2018-08-08 0001564590-18-020497
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 235,000 2020-01-01 2020-12-31 2022 FY 10-K 2023-02-27 0000950170-23-004655
us-gaap PaymentsOfDividends Payments of Dividends USD 31.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 172,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap PaymentsToAcquireAdditionalInterestInSubsidiaries Payments to Acquire Additional Interest in Subsidiaries USD 3.09M 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021191
us-gaap PaymentsToAcquireBuildings Payments to Acquire Buildings USD 15.60M 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-06 0001193125-15-079092
us-gaap PaymentsToAcquireBusinessesGross Payments to Acquire Businesses, Gross USD 60.40M 2016-01-01 2016-12-31 2018 FY 10-K 2019-02-27 0001564590-19-004923
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 3.30M 2014-08-01 2014 Q3 10-Q 2014-11-07 0001193125-14-402048
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 191,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 7.62M 2023-01-01 2023-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap PaymentsToAcquireRealEstate Payments to Acquire Real Estate USD 11.81M 2011-01-01 2011-06-30 2011 Q2 10-Q 2011-08-08 0001193125-11-213342
us-gaap PaymentsToFundLongtermLoansToRelatedParties Payments to Fund Long-term Loans to Related Parties USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap PercentageRent Operating Leases, Income Statement, Percentage Revenue USD 4.99M 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-27 0001564590-19-004923
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 5.00M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2013-12-31 2013 FY 10-K 2014-03-07 0001193125-14-087617
us-gaap ProceedsFromCollectionOfAdvanceToAffiliate Proceeds from Collection of Advance to Affiliate USD 216,000 2017-01-01 2017-12-31 2019 FY 10-K 2020-02-26 0001564590-20-006816
us-gaap ProceedsFromCollectionOfLongtermLoansToRelatedParties Proceeds from Collection of Long-term Loans to Related Parties USD 3.50M 2023-01-01 2023-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap ProceedsFromDivestitureOfBusinessesNetOfCashDivested Proceeds from Divestiture of Businesses, Net of Cash Divested USD 33.80M 2011-01-01 2011-12-31 2013 FY 10-K 2014-03-07 0001193125-14-087617
us-gaap ProceedsFromInsuranceSettlementInvestingActivities Proceeds from Insurance Settlement, Investing Activities USD 4.97M 2017-01-01 2017-12-31 2019 FY 10-K 2020-02-26 0001564590-20-006816
us-gaap ProceedsFromIssuanceOfSecuredDebt Proceeds from Issuance of Secured Debt USD 13.00M 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008850
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 35,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-08 0000950170-25-067009
us-gaap ProceedsFromLinesOfCredit Proceeds from Lines of Credit USD 21.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap ProceedsFromLongTermLinesOfCredit Proceeds from Long-term Lines of Credit USD 50.10M 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-08 0001564590-16-028351
us-gaap ProceedsFromMinorityShareholders Proceeds from Noncontrolling Interests USD 0 2011-01-01 2011-12-31 2011 FY 10-K 2012-03-13 0001193125-12-111276
us-gaap ProceedsFromPaymentsForLongTermLoansForRelatedParties Proceeds from Collection of (Payments to Fund) Long-term Loans to Related Parties USD 3.50M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021191
us-gaap ProceedsFromRepaymentsOfLinesOfCredit Proceeds from (Repayments of) Lines of Credit USD 8.30M 2020-01-01 2020-06-30 2020 Q2 10-Q 2020-08-07 0001564590-20-038417
us-gaap ProceedsFromRepaymentsOfNotesPayable Proceeds from (Repayments of) Notes Payable USD 22.60M 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-28 0001564590-18-003812
us-gaap ProceedsFromRepurchaseOfEquity Proceeds from (Repurchase of) Equity USD 117,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap ProceedsFromSaleOfLandHeldForUse Proceeds from Sale of Land Held-for-use USD 746,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap ProceedsFromSaleOfOtherPropertyPlantAndEquipment Proceeds from Sale of Other Property, Plant, and Equipment USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-06 0001193125-15-079092
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 746,000 2026-06-01 2026-06-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap ProceedsFromSaleOfRealEstateHeldforinvestment Proceeds from Sale of Real Estate Held-for-investment USD 3.89M 2023-01-01 2023-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD 15.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap RealEstateAccumulatedDepreciation SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Accumulated Depreciation USD 312.98M 2025-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap RealEstateAccumulatedDepreciationDepreciationExpense Real Estate Accumulated Depreciation, Depreciation Expense (Deprecated 2013-01-31) USD 12.22M 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-13 0001193125-13-105230
us-gaap RealEstateAccumulatedDepreciationOtherDeductions SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Accumulated Depreciation, Other Deduction USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap RealEstateAccumulatedDepreciationPeriodIncreaseDecrease SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Accumulated Depreciation, Period Increase (Decrease) USD 4.85M 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-27 0000950170-24-021191
us-gaap RealEstateAccumulatedDepreciationRealEstateSold SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Accumulated Depreciation, Investment in Real Estate Sold USD 1.59M 2013-01-01 2013-12-31 2015 FY 10-K 2016-03-04 0001564590-16-014024
us-gaap RealEstateAcquisitionsThroughForeclosures SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Acquisition Through Foreclosure USD 10.13M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap RealEstateAndAccumulatedDepreciationAmountOfEncumbrances SEC Schedule III, Real Estate and Accumulated Depreciation, Amount of Encumbrances USD 75.74M 2017-12-31 2017 FY 10-K 2018-02-28 0001564590-18-003812
us-gaap RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, Building and Improvements, Amount USD 661.88M 2025-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap RealEstateAndAccumulatedDepreciationCarryingAmountOfLand SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, Land, Amount USD 56.87M 2025-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, Initial Cost of Building and Improvements USD 564.96M 2025-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap RealEstateAndAccumulatedDepreciationInitialCostOfLand SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate and Accumulated Depreciation, Initial Cost of Land USD 54.03M 2025-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap RealEstateCostOfRealEstateSold SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Cost of Investment in Real Estate Sold USD 13.19M 2013-01-01 2013-12-31 2015 FY 10-K 2016-03-04 0001564590-16-014024
us-gaap RealEstateFederalIncomeTaxBasis SEC Schedule III, Real Estate, Federal Income Tax Basis USD 384.00M 2017-12-31 2017 FY 10-K 2018-02-28 0001564590-18-003812
us-gaap RealEstateGrossAtCarryingValue SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Gross USD 722.99M 2025-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap RealEstateInvestmentPropertyAccumulatedDepreciation Real Estate Investment Property, Accumulated Depreciation USD 332.01M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap RealEstateInvestmentPropertyAtCost Real Estate Investment Property, at Cost USD 692.49M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap RealEstateInvestmentPropertyNet Real Estate Investment Property, Net USD 360.48M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap RealEstateInvestments Real Estate Investments, Net USD 417.33M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures Real Estate Investments, Unconsolidated Real Estate and Other Joint Ventures USD 16.30M 2013-12-31 2013 FY 10-K 2014-03-07 0001193125-14-087617
us-gaap RealEstateOtherAcquisitions SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Other Acquisition USD 84.06M 2014-01-01 2014-12-31 2016 FY 10-K 2017-02-28 0001564590-17-002865
us-gaap RealEstatePeriodIncreaseDecrease SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Period Increase (Decrease) USD -24.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap RepaymentsOfLinesOfCredit Repayments of Lines of Credit USD 20.45M 2017-01-01 2017-12-31 2019 FY 10-K 2020-02-26 0001564590-20-006816
us-gaap RepaymentsOfLongTermLinesOfCredit Repayments of Long-term Lines of Credit USD 0 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-07 0001193125-14-087617
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 94,000 2011-01-01 2011-09-30 2011 Q3 10-Q 2011-11-07 0001193125-11-299513
us-gaap RepaymentsOfSecuredDebt Repayments of Secured Debt USD 447,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 11.25M 2017-06-30 2018 Q2 10-Q 2018-08-08 0001564590-18-020497
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD 878.76M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 9.20M 2018-01-01 2018-12-31 2019 FY 10-K 2020-02-26 0001564590-20-006816
us-gaap Revenues Revenues USD 74.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 8.97M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-08 0001564590-19-042274
us-gaap SalesOfRealEstate Sales of Real Estate (Deprecated 2018-01-31) USD 8.47M 2017-01-01 2017-12-31 2017 FY 10-K 2018-02-28 0001564590-18-003812
us-gaap SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Accumulated Depreciation, Depreciation Expense USD 26.05M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap SECScheduleIIIRealEstateWritedownOrReserveAmount SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Write-down or Reserve, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap SecuredDebt Secured Debt USD 18.01M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 617,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 310,040 2015-12-31 2015 FY 10-K 2016-03-04 0001564590-16-014024
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 23,000 2015-12-31 2015 FY 10-K 2016-03-04 0001564590-16-014024
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 36.53 2015-12-31 2015 FY 10-K 2016-03-04 0001564590-16-014024
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 0 2015-12-31 2015 FY 10-K 2016-03-04 0001564590-16-014024
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 176,240 2013-12-31 2013 FY 10-K 2014-03-07 0001193125-14-087617
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 0 2021-12-31 2021 FY 10-K 2022-02-24 0001564590-22-006745
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 36.53 2015-12-31 2018 FY 10-K 2019-02-27 0001564590-19-004923
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 36.53 2016-01-01 2016-12-31 2018 FY 10-K 2019-02-27 0001564590-19-004923
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price USD/shares 35.22 2012-12-31 2012 FY 10-K 2013-03-13 0001193125-13-105230
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price USD/shares 35.22 2012-12-31 2012 FY 10-K 2013-03-13 0001193125-13-105230
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 139.50M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 139.50M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 0 2024-04-30 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-24 0001564590-22-006745
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 117,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 520,420 2016-01-01 2016-12-31 2018 FY 10-K 2019-02-27 0001564590-19-004923
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 58,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap TaxBasisOfInvestmentsCostForIncomeTaxPurposes Tax Basis of Investments, Cost for Income Tax Purposes USD 740.00M 2025-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap UnusualOrInfrequentItemInsuranceProceeds Unusual or Infrequent Item, or Both, Insurance Proceeds USD 1.16M 2018-01-01 2018-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008850
us-gaap UnusualOrInfrequentItemLossGross Unusual or Infrequent Item, or Both, Loss, Gross USD 4.97M 2017-01-01 2017-12-31 2019 FY 10-K 2020-02-26 0001564590-20-006816
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 43,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-25 0001193125-26-071594
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 13.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 13.72M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-08 0001564590-18-028574
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 13.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001193125-26-451858

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →